Document is current
Any future updates will be listed below
-
Authors
Vear, Anika https://orcid.org/0000-0003-1777-2448
Heneka, Michael T. https://orcid.org/0000-0003-4996-1630
Clemmensen, Christoffer https://orcid.org/0000-0003-2456-9667
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden
- License Information
-
More Information
Article History
Received: 1 October 2024
Accepted: 6 March 2025
First Online: 10 April 2025
Competing interests
: C.C. is a cofounder of Ousia Pharma, a biotechnology company developing therapeutics for treatment of obesity. M.T.H. is a scientific advisory board member at Alector the Dementia Discovery Fund and Muna Therapeutics and has received honoraria for oral presentations from Pfizer, Novartis, Roche, Abbvie and Biogen. A.V. does not declare any competing interests.
